Familial associations between cancer sites

Computers and Biomedical Research

Volumn 32, Issue 6, 1999, Pages 517-529

  Thomas, Alun ^a   Cannon Albright, Lisa ^b   Bansal, Aruna ^b   Skolnick, Mark H ^a  

^a Myriad Genetic Laboratories   (United States)

^b NONE

Author keywords

Association; Cancer; Genealogy; Kinships

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CONTROLLED STUDY; DATA BASE; FAMILIAL CANCER; GENEALOGY; GENETIC PREDISPOSITION; HUMAN; PRIORITY JOURNAL; UNITED STATES;

EID: 0033386485     PISSN: 00104809     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbmr.1999.1525     Document Type: Article

References (42)

1. Skolnick M. Prospects for population oncogenetics. Mulvihill J. J., Miller R. W., Fraumeni J. F. Jr. Genetics of Human Cancer. 1977;19-25 Raven Press, New York.
2. Skolnick M. The Utah genealogical database: A resource for genetics epidemiology. Cairns J., Lyon J. L., Skolnick M. Banbury Report No. 4: Cancer Incidence in Defined Populations. 1980;285-297 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
3. Skolnick M., Bean L., May D., Arbon V., de Nevers K., Cartwright P. Mormon demographic history. I. Nuptiality and fertility of once-married couples. Pop. Stud. 32:1978;5.
4. Skolnick M., Bean L. L., Dintelman S. M., Mineau G. A computerized family history data base system. Sociol. Soc. Res. 63:1979;506.
5. Hill J. A Kinship Survey of Cancer in the Utah Mormon Population. 1980;Ph.D. thesis, University of Utah, Salt Lake City.
6. Hill J. A survey of cancer sites by kinship in the Utah Mormon population. Cairns J., Lyon J. L., Skolnick M. Banbury Report No. 4: Cancer Incidence in Defined Populations. 1980;299-318 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
7. Skolnick M., Bishop D. T., Carmelli D., Gardner E., Hadely R., Hastedt S., Hill J. R., Hunt S., Lyon J. L., Smart C. R. A population-based assessment of familial cancer risk in Utah Mormon genealogies. Arrighi F. E., Rao R. N., Stubblefield E. Genes, Chromosomes, and Neoplasma. 1981;477-500 Raven Press, New York.
8. Cannon L., Bishop D. T., Skolnick M., Hunt S., Lyon J. L., Smart C. R. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv. 1:1982;48.
9. Bishop, D. T., and Skolnick, M. H. (1984), Genetic epidemiology of cancer in Utah genealogies: A prelude to the molecular genetics of common cancers. In "Cellular and Molecular Biology of Neoplasia" (T. W. Mak and I. Tannock, Eds.), Vol. 3, J. Cell Physiol. Suppl., pp. 63-77, 1984.
10. Goldgar D. E., Easton D. F., Cannon-Albright L. A., Skolnick M. H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl. Cancer Inst. 86:1994;1600.
11. Cannon-Albright L. A., Thomas A., Goldgar D. E., Gholami K., Rowe K., Jacobsen M., McWhorter W. P., Skolnick M. H. Familiality of cancer in Utah. Cancer Res. 54:1994;2378.
12. McLellan T., Jorde L. B., Skolnick M. H. Genetic distances between the Utah Mormons and related populations. Am. J. Hum. Genet. 36:1984;836.
13. Jorde L. B., Skolnick M. H. Demographic and genetic application of computerized record linking: The Utah Mormon genealogy. Inform. Sci. Hum. 105:1981;56-57.
14. Field Trial Edition, World Health Organization. 1988.
15. Cannon-Albright L. A., Jacobsen M., McWhorter W. P. Classification of Cancer by Site in the Utah Population Database. Technical Report. 1993.
16. Cancer in Utah Report. 1997;1967-1977.
17. Lyon J. L., Gardner J., West D. Cancer incidence in Mormons and non-Mormons in Utah during 1967-1975. J. Natl. Cancer Inst. 65:1980;1055.
18. Newcombe H. B., Kennedy J. M. Record linkage: making maximum use of the discriminating power of identifying information. Commun. Assoc. Comput. Machinery. 5:1962;563.
19. Hill T. Generalized Iterative Record Linking System. GIRLS. 1981;Statistics Canada, Ottawa.
20. Jaro M. A. Advances in record-linkage methodology as applied to the 1985 census of Tampa, Florida. J. Am. Stat. Assoc. 84:1989;414.
21. Malecot G. Les Mathematiques de l'Heredite. 1948;Masson et Cie.
22. Gholami K., Thomas A. A linear time algorithm for calculation of multiple pairwise kinship coefficients and the genetic index of familiality. Comput. Biomed. Res. 27:1994;342.
23. Lynch H. T., Krusch A. J., Thomas R. J., Lynch J. Cancer family syndrome. Cancer Genetics. 1976;Thomas. p. 355-388.
24. Frisch M., Melbye M. Nye cancere efter planocellulaer hudcancer. Ugeskr Laeger. 158:1996;1079.
25. Graham S., Blanchet M., Rohrer T. Cancer in asbestos-mining and other areas of Quebec. J. Natl. Cancer Inst. 59:1997;1139.
26. Cancer in Utah 1966-1990. 1992;Utah Cancer Registry.
27. Marsh D. J., Coulon V., Lunetta K. L., Rocca-Serra P., Dahia P. L., Zheng Z., Liaw D., Caron S., Duboue B., Lin A. Y., Richardson A. L., Bonnetblanc J. M., Bressieux J. M., Cabarrot-Moreau A., Chompret A., Demange L., Eeles R. A., Yahanda A. M., Fearon E. R., Fricker J. P., Gorlin R. J., Hodgson S. V., Huson S., Lacombe D., LePrat F., Odent S., adn O I Olopade C. T., Sobol M., Tishler S., Woods C. G., Robinson B. G., Weber H. C., Parsons R., Peackocke M., Longy M., Eng C. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet. 7:1998;507.
28. Teng D. H., Hu R., Lin H., Davis T., Iliev D., Frye C., Swedlund B., Hansen K. L., Vinson V. L., Gumpper K. L., Ellis L., El-Naggar A., Frazier M., Jasser S., Langford L. A., Lee J., Mills G. B., Pershouse M. A., Pollack R. E., Tornos C., Troncoso P., Yung W. K., Fujii G., Berson A., Steck P. A. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57:1997;5221.
29. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S., Johnson B. E., Skolnick M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1944;436.
30. Weaver-Feldhaus J., Gruis N. A., Neuhausen S., Paslier D. L., Stockert E., Skolnick M. H., Kamb A. Localisation of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc. Natl. Acad. Sci. USA. 91:1994;7563.
31. Hall J. M., Lee M. K., Newman B., Morrow J. E., Anderson L. A., Huey B., King M. C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 250:1990;1684.
32. Narod S. A., Feunteun J., Lynch H. T., Lenoir G. M. Familial breast-ovarian cancer locus on chromosome 17q21-23. Lancet. 338:1991;82.
33. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R., Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow P. K., Norris F. H., Helvering L., Morrison P., Rosteck P., Lai M., Barrett J. C., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R., Kamb A., Skolnick M. H. A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1. Science. 266:1994;66.
34. Ford D. F., Easton D. F., Bishop D. T., Narod S. A., Goldgar D. E. Risks of cancer in BRCA1-mutation carriers. Lancet. 343:1994;692.
35. Wooster R., Neuhausen S., Mangion J., Quirk Y., Ford D., Collins N., Nguyen K., Seal S., Tran T., Averill D., Fields P., Marshall G., Narod S., Lenoir G., Lunch H., Feunteun J., Devilee P., Conelisse C. J., Menko F. H., Daly P. A., Orminston W., adn C Pye R. M., Lewis C. M., adn J Peto C.-A L., Ponder B. A J., Skolnick M. H., Easton D. F., Goldgar D. E., Stratton M. R. Localization of a breast cancer susceptibility gene to chromosome 13q12-q13. Science. 265:1994;2088.
36. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789.
37. Easton D. F., Steele L., Fields P., Ormiston W., Averill D., Daly P. A., McManus R., Neuhausen S. L., Ford D., Wooster R., Cannon-Albright L. A., Stratton M. R., Goldgar D. E. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am. J. Hum. Genet. 61:1997;120.
38. Li F. P., Fraumeni J. F. Jr. Soft tissue sarcomas, breast cancer. and other neoplasms. A familial syndrome? Ann. Intern. Med. 71:1969;747.
39. Li F. P., Fraumeni J. F. Jr. Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome. J. Natl. Cancer Inst. 43:1969;1364.
40. Lynch H. T., Krusch A. J., Guirgis H. Genetic factors in families with combined gastrointestinal and breast cancer. Am. J. Gastroeneterol. 59:1973;31.
41. Lynch H. T., Guirgis H. A., Albert S., Lynch M. B., Kraft C., Pocekay D., Vaughns C., Kaplan A. Familial association of carcinoma of the breast and ovary. Surgery. 138:1974;717.
42. Isaacs S. D., Kiemeney L. A., Baffoe-Bonnie A., Beaty T. H., Walsh P. C. Risk of cancer in relatives of prostate cancer probands. J. Natl. Cancer Inst. 87:1995;991.